[Clinico-pharmacological and clinical evaluation of pengitoxin].
D000113:Acetyldigoxins / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D001682:Biological Availability; D004074:Digitoxin / Q000378:metabolism; D004077:Digoxin / Q000031:analogs & derivatives* / Q000378:metabolism; D006331:Heart Diseases / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007700:Kinetics
D000113:Acetyldigoxins; C016034:pentaacetylgitoxin; D004077:Digoxin; D004074:Digitoxin
Kliniko-farmakologicheskoe i klinicheskoe issledovanie pengitoksina.